For Investor Relations

Get Ahead of Questions To Protect Market Value

AppliedXL shows IR teams what’s happening across their own pipeline and competitors, so you can spot risks early, prepare leadership, and guide investor messaging with confidence.

Full Visibility, Fewer Surprises.

Spot your own risks before investors do

Catch delays or enrollment gaps early so you can address them before they hit the market and impact valuation.

Build credibility with transparent updates

Ground your communications in structured, timestamped trial data, accelerate speed to insight for investors with clear, verifiable facts.

Control the narrative, not just react

Anticipate investor questions by spotting issues early, save time by preparing responses before speculation builds.

Strengthen confidence in your story

Use structured trial visibility to reinforce guidance, avoid blind spots and reduce the risk of surprises that shake confidence.

"When a substantial delay for one our studies popped up in the registry, we got the alert before investors spotted it. We briefed leadership the same day, so by the time questions came in on the earnings call, we already had the response lined up."

Head of IR & Comms
Global Pharma Company

"We quickly saw that two other companies with competing assets in the same indication were facing similar enrollment challenges. That gave us the data to show our investors wasn’t specific to our trial, but a broader issue with patient recruitment in this disease area across key U.S. regions."

VP, IR & Comms
Series B, Clinical Stage Biotech Company

"I’ve got one feed tracking every trial in our pipeline, and separate feeds for key competitors in our main therapeutic areas. It saves me hours each week."

VP Investor Relations
Nasdaq-Listed Biotech

The risk was in the data, but you didn’t see it.

Catch trial disruptions early and adjust positions before the market reacts.

Latest Updates